Juerg Gertsch (J Gertsch, Jürg Gertsch)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 22

Top Venues

ACS pharmacology & translational science

ChemMedChem

bioRxiv : the preprint server for biology

Journal of medicinal chemistry

University of Bern

ETH-Bereich Hochschulen (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Bern

Switzerland

Full Professor :: Institute of Biochemistry and Molecular Medicine

Education History

ETH-Bereich Hochschulen

Switzerland

PHD :: D-CHAB

University of Sussex

United Kingdom

MSC

Publications

Andrea Chicca, Daniel Bátora, Christoph Ullmer, Antonello Caruso, Sabine Grüner, Jürgen Fingerle, Thomas Hartung, Roland Degen, Matthias Müller, Uwe Grether, Pal Pacher, Juerg Gertsch
A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo Studies. ACS pharmacology & translational science 7 (8) (2024)
Muhammad Bello Saidu, Gordana Krstić, Anita Barta, Attila Hunyadi, Róbert Berkecz, Umar Shehu Gallah, Kaushavi Cholke, Juerg Gertsch, Peter Waweru Mwangi, Judit Hohmann
Euphane and Tirucallane Triterpenes with Trypanocidal Activity from Euphorbia desmondii . Journal of natural products (2024)
Daniel Bátora, Rowan Iskandar, Juerg Gertsch, Reto M Kaderli
Impact of perioperative diagnostic tools on clinical outcomes and cost-effectiveness in parathyroid surgery: a decision model-based analysis. BMJ open 14 (9) (2024)
Daniel Bátora, Jérôme P Fischer, Reto M Kaderli, Máté Varga, Martin Lochner, Juerg Gertsch
Silicon-Rhodamine Functionalized Evocalcet Probes Potently and Selectively Label Calcium Sensing Receptors In Vitro , In Vivo , and Ex Vivo . ACS pharmacology & translational science 7 (5) (2024)
Andrea Chicca, Daniel Bátora, Christoph Ullmer, Antonello Caruso, Sabine Grüner, Jürgen Fingerle, Thomas Hartung, Roland Degen, Matthias Müller, Uwe Grether, Pal Pacher, Juerg Gertsch
A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo Studies. ACS pharmacology & translational science 7 (8) (2024)
Andrea Chicca, Daniel Bátora, Christoph Ullmer, Antonello Caruso, Jürgen Fingerle, Thomas Hartung, Roland Degen, Matthias Müller, Uwe Grether, Pal Pacher, Juerg Gertsch
A highly potent, orally bioavailable pyrazole-derived cannabinoid CB2 receptor-selective full agonist for in vivo studies. bioRxiv : the preprint server for biology (2024)
Daniel Bátora, Jérôme P Fischer, Reto M Kaderli, Máté Varga, Martin Lochner, Juerg Gertsch
Silicon-Rhodamine Functionalized Evocalcet Probes Potently and Selectively Label Calcium Sensing Receptors In Vitro , In Vivo , and Ex Vivo . ACS pharmacology & translational science 7 (5) (2024)
Andrea Chicca, Daniel Bátora, Christoph Ullmer, Antonello Caruso, Jürgen Fingerle, Thomas Hartung, Roland Degen, Matthias Müller, Uwe Grether, Pal Pacher, Juerg Gertsch
A highly potent, orally bioavailable pyrazole-derived cannabinoid CB2 receptor-selective full agonist for in vivo studies. bioRxiv : the preprint server for biology (2024)
Andrea Chicca, Daniel Bátora, Christoph Ullmer, Antonello Caruso, Sabine Grüner, Jürgen Fingerle, Thomas Hartung, Roland Degen, Matthias Müller, Uwe Grether, Pal Pacher, Juerg Gertsch
A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo Studies. ACS pharmacology & translational science 7 (8) (2024)
Andrea Chicca, Daniel Bátora, Christoph Ullmer, Antonello Caruso, Jürgen Fingerle, Thomas Hartung, Roland Degen, Matthias Müller, Uwe Grether, Pal Pacher, Juerg Gertsch
A highly potent, orally bioavailable pyrazole-derived cannabinoid CB2 receptor-selective full agonist for in vivo studies. bioRxiv : the preprint server for biology (2024)
Julien Graff, Jennifer Müller, Anna Sadurní, Matthias Rubin, Inês André Canivete Cuissa, Claudia Keller, Marco Hartmann, Simon Singer, Juerg Gertsch, Karl-Heinz Altmann
The Evaluation of l-Tryptophan Derivatives as Inhibitors of the l-Type Amino Acid Transporter LAT1 (SLC7A5). ChemMedChem 17 (17) (2022)
Liad Hinden, Majdoleen Ahmad, Sharleen Hamad, Alina Nemirovski, Gergő Szanda, Sandra Glasmacher, Aviram Kogot-Levin, Rinat Abramovitch, Bernard Thorens, Juerg Gertsch, Gil Leibowitz, Joseph Tam
Opposite physiological and pathological mTORC1-mediated roles of the CB1 receptor in regulating renal tubular function. Nature communications 13 (1) (2022)
Jean-Marc Jeckelmann, Jonas Zaugg, Veronika Morozova, Jennifer Müller, Satish Kantipudi, Mariana Schroeder, Julien Graff, Christiane Albrecht, Karl-Heinz Altmann, Juerg Gertsch, Dimitrios Fotiadis
Structure, Function and Pharmacology of SLC7 Family Members and Homologues. Chimia 76 (12) (2022)
Christian Paul Bold, Melanie Gut, Jasmine Schürmann, Daniel Lucena-Agell, Juerg Gertsch, José Fernando Díaz, Karl-Heinz Altmann
Synthesis of Morpholine-Based Analogues of (-)-Zampanolide and Their Biological Activity. Chemistry (Weinheim an der Bergstrasse, Germany) 27 (19) (2021)
Jonas Zaugg, Xiao Huang, Fabian Ziegler, Matthias Rubin, Julien Graff, Jennifer Müller, Ruedi Moser-Hässig, Theresa L Powell, Juerg Gertsch, Karl-Heinz Altmann, Christiane Albrecht
Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno-foetal amino acid transport. Journal of cellular and molecular medicine 24 (21) (2020)
Patrick Mäder, Ruben Bartholomäus, Simon Nicolussi, Alice Baumann, Melanie Weis, Andrea Chicca, Mark Rau, Ana Catarina Simão, Juerg Gertsch, Karl-Heinz Altmann
Synthesis and Biological Evaluation of Endocannabinoid Uptake Inhibitors Derived from WOBE437. ChemMedChem 16 (1) (2020)
Carlotta Granchi, Margherita Lapillo, Sandra Glasmacher, Giulia Bononi, Cristina Licari, Giulio Poli, Maguie El Boustani, Isabella Caligiuri, Flavio Rizzolio, Juerg Gertsch, Marco Macchia, Filippo Minutolo, Tiziano Tuccinardi, Andrea Chicca
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor. Journal of medicinal chemistry 62 (4) (2019)
Ruben Bartholomäus, Simon Nicolussi, Alice Baumann, Mark Rau, Ana Catarina Simão, Juerg Gertsch, Karl-Heinz Altmann
Total Synthesis of the Endocannabinoid Uptake Inhibitor Guineensine and SAR Studies. ChemMedChem 14 (17) (2019)
Andrea Salm, Juerg Gertsch
Cultural perception of triatomine bugs and Chagas disease in Bolivia: a cross-sectional field study. Parasites & vectors 12 (1) (2019)
Andrea Chicca, Michael A Schafroth, I Reynoso-Moreno, Reto Erni, V Petrucci, Erick M Carreira, Juerg Gertsch
Uncovering the psychoactivity of a cannabinoid from liverworts associated with a legal high. Science advances 4 (10) (2018)
Mojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Stefania Baraldi, Emanuela Ruggiero, Lucia De Stefano, Flavio Rizzolio, Lorenzo Di Cesare Mannelli, Carla Ghelardini, Andrea Chicca, Margherita Lapillo, Juerg Gertsch, Clementina Manera, Marco Macchia, Adriano Martinelli, Carlotta Granchi, Filippo Minutolo, Tiziano Tuccinardi
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors. Journal of medicinal chemistry 61 (3) (2018)
Inés Reynoso-Moreno, Israel Najar-Guerrero, Noé Escareño, Mario Eduardo Flores-Soto, Juerg Gertsch, Juan Manuel Viveros-Paredes
An Endocannabinoid Uptake Inhibitor from Black Pepper Exerts Pronounced Anti-Inflammatory Effects in Mice. Journal of agricultural and food chemistry 65 (43) (2017)

Juerg Gertsch.css-eqlu8i{font-size:small;padding-left:4px;} (J Gertsch, Jürg Gertsch)

Publication Activity (10 Years)

Top Topics

Top Venues

Juerg Gertsch (J Gertsch, Jürg Gertsch)